Role of autophagy on the modulation of CYP2E1 alcohol liver toxicity

自噬在调节 CYP2E1 酒精肝毒性中的作用

基本信息

项目摘要

DESCRIPTION (provided by applicant): Alcohol-induced liver injury is a significant global health problem and a leading cause of death. The mechanisms by which ethanol treatment causes cell death are not clear. CYP2E1 is induced by ethanol, is an active producer of reactive oxygen species and plays a role in ethanol-induced liver injury. Autophagy is a lysosomal-mediated pathway for removal and recycling of long-lived proteins, cellular organelles and lipid droplets. The goal of this R21 application is to evaluate whether autophagy can modulate CYP2E1-dependent ethanol toxicity in vitro and in vivo after acute and chronic ethanol treatment. The rationale is that CYP2E1 plays a role in ethanol-induced oxidant stress, fatty liver and liver injury. Autophagy, in some settings is protective against cell injury, while in other settings autophagy can promote cell toxicity. If autophagy is protective against ethanol/CYP2E1 toxicity, attempts to stimulate autophagy may prove to be helpful in lowering ethanol-induced liver injury. If autophagy promotes ethanol/CYP2E1 toxicity, inhibitors of autophagy may help to ameliorate ethanol hepatotoxicity. We will treat HepG2 cells which express CYP2E1 (E47 cells) or do not (C34 cells) with ethanol (0-100mM, 1-10 days) in the absence and presence of inhibitors of autophagy or activators of autophagy and assay the following: cell viability, apoptosis, oxidant stress, levels and activity of CYP2E1, mitochondrial dysfunction, steatosis, activation of mitogen activated protein kinases, hepatoprotective defense, autophagy and autophagy regulators such as Bcl-2, AMPK, mTOR. For in- vivo studies, wild type SV129 mice, SV129 CYP2E1 knockout (KO) mice, and SV129 CYP2E1 knockin (KI) mice in which human CYP2E1 has been "knocked" in will be treated acutely with ethanol (3g/kg, body wt. twice a day for 1, 2 and 4 days) or saline or be fed the high fat Lieber-DeCarli diet containing ethanol or isocaloric dextrose for 2 to 8 weeks. Some mice will also be treated with the autophagy inhibitor 3-methyladenine or the autophagy activator rapamycin. The effects of acute and chronic ethanol in the absence and presence of modifiers of autophagy in WT mouse with "normal" levels of mouse CYP2E1, in KO mice without CYP2E1 and in KI mice with elevated levels of human CYP2E1 on reactions described above will be evaluated. Time course experiments are designed to help define the sequence of events from the interactions between ethanol and CYP2E1 when autophagy is inhibited or activated. Time course experiments may also be informative as to whether the acute or chronic ethanol feeding may initially activate autophagy as an adaptive response to ethanol, which subsequently is not sustained with more prolonged acute ethanol treatment or chronic ethanol feeding. PUBLIC HEALTH RELEVANCE: CYP2E1 plays a major role in ethanol-induced liver injury. Autophagy can protect or promote cell toxicity. We will evaluate whether autophagy can modulate CYP2E1-dependent ethanol toxicity after acute and chronic ethanol treatment.
描述(由申请人提供):酒精性肝损伤是一个重要的全球性健康问题,也是导致死亡的主要原因。乙醇处理导致细胞死亡的机制尚不清楚。CYP 2 E1由乙醇诱导,是活性氧的活性产生者,在乙醇诱导的肝损伤中起作用。自噬是溶酶体介导的清除和回收长寿命蛋白质、细胞器和脂滴的途径。这项R21应用的目的是评估自噬是否可以调节急性和慢性乙醇治疗后的CYP 2 E1依赖性乙醇毒性的体外和体内研究。其基本原理是CYP 2 E1在乙醇诱导的氧化应激、脂肪肝 和肝损伤。在某些情况下,自噬可以保护细胞免受损伤,而在其他情况下,自噬可以促进细胞毒性。如果自噬对乙醇/CYP 2 E1毒性具有保护作用,那么刺激自噬可能有助于降低乙醇诱导的肝损伤。如果自噬促进乙醇/CYP 2 E1毒性,则自噬抑制剂可能有助于改善乙醇肝毒性。我们将处理表达CYP 2 E1的HepG 2细胞,(E47细胞)或不(C34细胞)与乙醇(0- 100 mM,1-10天),并测定以下:细胞活力、细胞凋亡、氧化应激、CYP 2 E1的水平和活性、线粒体功能障碍、脂肪变性、促分裂原活化蛋白激酶的活化,肝保护防御、自噬和自噬调节剂如Bcl-2、AMPK、mTOR。对于体内研究,野生型SV 129小鼠、SV 129 CYP 2 E1敲除(KO)小鼠和其中人CYP 2 E1已“敲入”的SV 129 CYP 2 E1敲入(KI)小鼠将用乙醇(3g/kg,体重)急性处理。每天两次,持续1、2和4天)或盐水,或喂食含有乙醇或等热量葡萄糖的高脂肪Lieber-DeCarli饮食2至8周。一些小鼠还将用自噬抑制剂3-甲基腺嘌呤或自噬激活剂雷帕霉素治疗。将评价在不存在和存在自噬调节剂的情况下,急性和慢性乙醇对具有“正常”小鼠CYP 2 E1水平的WT小鼠、不具有CYP 2 E1的KO小鼠和具有升高的人CYP 2 E1水平的KI小鼠的上述反应的影响。时程实验旨在帮助定义自噬被抑制或激活时乙醇和CYP 2 E1之间相互作用的事件顺序。时间过程实验也可以提供关于急性或慢性乙醇喂养是否可以最初激活自噬作为对乙醇的适应性反应的信息,随后不被更长时间的急性乙醇治疗或慢性乙醇喂养所持续。 公共卫生相关性:CYP 2 E1在乙醇诱导的肝损伤中起主要作用。自噬可以保护或促进细胞毒性。我们将评估急性和慢性乙醇治疗后,自噬是否可以调节CYP 2 E1依赖性乙醇毒性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ARTHUR I CEDERBAUM其他文献

ARTHUR I CEDERBAUM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ARTHUR I CEDERBAUM', 18)}}的其他基金

Role of autophagy on the modulation of CYP2E1 alcohol liver toxicity
自噬在调节 CYP2E1 酒精肝毒性中的作用
  • 批准号:
    8508151
  • 财政年份:
    2012
  • 资助金额:
    $ 24.37万
  • 项目类别:
Alcohol-Induced Fatty Liver and Injury in Humanized CYP2E1 Knockin Mice.
人源化 CYP2E1 敲入小鼠中酒精诱导的脂肪肝和损伤。
  • 批准号:
    7933539
  • 财政年份:
    2009
  • 资助金额:
    $ 24.37万
  • 项目类别:
Alcohol-Induced Fatty Liver and Injury in Humanized CYP2E1 Knockin Mice.
人源化 CYP2E1 敲入小鼠中酒精诱导的脂肪肝和损伤。
  • 批准号:
    7795355
  • 财政年份:
    2009
  • 资助金额:
    $ 24.37万
  • 项目类别:
Role of CYP2E1 in TNFa-Ethanol -induced Liver Injury
CYP2E1 在 TNFa-乙醇诱导的肝损伤中的作用
  • 批准号:
    7727110
  • 财政年份:
    2009
  • 资助金额:
    $ 24.37万
  • 项目类别:
Role of CYP2E1 in TNFa-Ethanol -induced Liver Injury
CYP2E1 在 TNFa-乙醇诱导的肝损伤中的作用
  • 批准号:
    8099762
  • 财政年份:
    2009
  • 资助金额:
    $ 24.37万
  • 项目类别:
Alcohol-Induced Fatty Liver and Injury in Humanized CYP2E1 Knockin Mice.
人源化 CYP2E1 敲入小鼠中酒精诱导的脂肪肝和损伤。
  • 批准号:
    8127679
  • 财政年份:
    2009
  • 资助金额:
    $ 24.37万
  • 项目类别:
Role of CYP2E1 in TNFa-Ethanol -induced Liver Injury
CYP2E1 在 TNFa-乙醇诱导的肝损伤中的作用
  • 批准号:
    7879924
  • 财政年份:
    2009
  • 资助金额:
    $ 24.37万
  • 项目类别:
Modulation by SAMe of CYP2E1-dependent Effects in Liver.
SAMe 对肝脏中 CYP2E1 依赖性效应的调节。
  • 批准号:
    6592556
  • 财政年份:
    2002
  • 资助金额:
    $ 24.37万
  • 项目类别:
Modulation by SAMe of CYP2E1-dependent Effects in Liver.
SAMe 对肝脏中 CYP2E1 依赖性效应的调节。
  • 批准号:
    6795965
  • 财政年份:
    2002
  • 资助金额:
    $ 24.37万
  • 项目类别:
Modulation by SAMe of CYP2E1-dependent Effects in Liver.
SAMe 对肝脏中 CYP2E1 依赖性效应的调节。
  • 批准号:
    6940853
  • 财政年份:
    2002
  • 资助金额:
    $ 24.37万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.37万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 24.37万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.37万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.37万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.37万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.37万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.37万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 24.37万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 24.37万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 24.37万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了